1→3)β-D-glucan assay in the diagnosis of invasive fungal infections -: Reply to Upton et al.

被引：0

作者：

Ostrosky-Zeichner, L

Finkelman, MA

机构：

[1] Univ Texas, Hlth Sci Ctr, Div Infect Dis, Houston, TX 77030 USA

[2] Associates Cape Cod Inc, E Falmouth, MA USA

来源：

CLINICAL INFECTIOUS DISEASES | 2006年 / 42卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1056 / 1056

页数：1

共 9 条

[1]

Hossain MA, 1997, J CLIN LAB ANAL, V11, P73, DOI 10.1002/(SICI)1098-2825(1997)11:2&lt

[2]

73::AID-JCLA1&gt

[3]

3.0.CO

[4]

2-L

[5] Understanding and using diagnostic tests [J].

Moyer, VA ;

Kennedy, KA .

CLINICS IN PERINATOLOGY, 2003, 30 (02) :189-+

[6] PLASMA (1-]3)-BETA-D-GLUCAN MEASUREMENT IN DIAGNOSIS OF INVASIVE DEEP MYCOSIS AND FUNGAL FEBRILE EPISODES [J].

OBAYASHI, T ;

YOSHIDA, M ;

MORI, T ;

GOTO, H ;

YASUOKA, A ;

IWASAKI, H ;

TESHIMA, H ;

KOHNO, S ;

HORIUCHI, A ;

ITO, A ;

YAMAGUCHI, H ;

SHIMADA, K ;

KAWAI, T .

LANCET, 1995, 345 (8941) :17-20

[7] β-D-glucan as a diagnostic adjunct for invasive fungal infections:: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome [J].

Odabasi, Z ;

Mattiuzzi, G ;

Estey, E ;

Kantarjian, H ;

Saeki, F ;

Ridge, RJ ;

Ketchum, PA ;

Finkelman, MA ;

Rex, JH ;

Ostrosky-Zeichner, L .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (02) :199-205

[8] Multicenter clinical evaluation of the (1→3) β-D-glucan assay as an aid to diagnosis of fungal infections in humans [J].

Ostrosky-Zeichner, L ;

Alexander, BD ;

Kett, DH ;

Vazquez, J ;

Pappas, PG ;

Saeki, F ;

Ketchum, PA ;

Wingard, J ;

Schiff, R ;

Tamura, H ;

Finkelman, MA ;

Rex, JH .

CLINICAL INFECTIOUS DISEASES, 2005, 41 (05) :654-659

[9] Contribution of (1→3)-β-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients:: a comparison with serial screening for circulating galactomannan [J].

Pazos, C ;

Pontón, J ;

Del Palacio, A .

JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (01) :299-305

← 1 →